Sign In
|
Register
|
About Corte Madera
|
Contact Us
Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast
|
Traffic
Corte Madera News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Corte Madera Gas Prices
Ski And Snow Reports
Financial Markets
American
American
Bakery
Asian
Brew Pubs
Bakery/Breakfast
California Cuisine
Coffee Houses
Chinese
Eating Places
Fast Food
Coffee Houses
Delicatessens
German
Fast Food
Greek
Hawaiian
Dessert, Ice Cream and Frozen Yogurt
Italian
Dog Friendly
Italian/Pizza
Jewish
Latin American
Lebanese
Mediterranean
Pizza
Seafood
Soul Food
Sports Bars
Steaks, Chops
Thai
Wine
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Attractions
Nightlife
Family Activities
Arts & Culture
Annual Events
Accommodations
Hotel and Motel Management
Hotels & Resorts
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Attractions & Entertainment
Air Tours
Amusement & Water Parks
Galleries
General Attractions
Jeep & Hummer Tours
Parks & Preserves
Theatre
Tours
ATV & Hummer Tours
Automotive
Auto Rental
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Motorcycles
Parts & Supplies
Repair & Service
Beauty & Fitness
Barbers
Beauty Salons
Dance Clubs & Studios
Fitness Programs
Health Clubs & Gyms
Weight Loss
Business & Professional Services
Appraisers
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Data Processing Service
Durable Goods
Employment Services, Placement & Agencies
Energy Services
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Graphic Design & Art
Human Resource Services
Management Services
Marketing & Advertising Services
Media Services
Office Furniture, Equipment & Supplies
Office Supplies
Printing & Publishing
Public Relations & Publicity
Research
Security & Investigative Services
Signs & Banners
Staffing & Support Services
Telecommunications
Trucking & Hauling
Video Production
Waste Management & Recycling
Wholesale
Commercial Contractors
Contractors
Architects
Building Contractors & Consultants
Carpentry
Concrete
Drywall, Plastering & Insulation
Electric
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Landscaping
Painting & Wallcovering
Plumbing
Roofing
Special Trade Contractors
Domestic Services
Child Care Services
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Misc. Financial Services
Mortgage Lenders
Personal
Golf
Government
City & County Government
Federal Government
National Government
State Government
Health and Medicine
Alternative Medicine / Acupuncture
Animal Health
Chiropractors
Counseling
Dentistry
Drug Stores & Pharmacies
Emergency Services
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Mental Health
Nutrition
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Floor Coverings
Furniture
Heating, Cooling & AC
Home Improvement Centers
Lamps & Lighting
Lawn & Garden
Masonry & Stone Work
Nurseries & Garden Centers
Painting & Wallcoverings
Plumbing
Roofing & Siding
Water Supply
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Audio & Visual
Computers, Electronics & Telecommunications
Industrial Supplies & Services
Media
Print Publications
Radio Stations
Television Stations
Meeting & Event Planning
Travel Arrangement & Services
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Live Music
Night Clubs
Personal Service
Barbers, Beauty Salons & Spas
Shoe Repair
Pets
Pet Shops
Pet Supplies & Food - Retail
Training
Veterinary Hospitals
Real Estate
Appraisers
Commercial
Condominiums
Developers
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Religion
Relocation
Movers
Storage
Restaurants
Bakery
Brew Pubs
Eating Places
Fast Food
Sports Bars
Steaks, Chops
Wine
Shopping
Accessories
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Convenience Stores
Department Stores
Discount Stores
Electronics
Flowers
Furniture
Gifts & Specialty Shops
Gourmet & Specialty Foods
Grocery Stores
Health Food Stores
Hobbies & Crafts
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Notions
Office Supplies & Service
Pharmacies
Resale Shops
Shoe Stores
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Sports & Recreation
Arenas and Venues
Associations & Clubs
Bicycles
Dance Clubs & Studios, Instruction
Fishing, Fishing Charters and Tours
Golf Courses
Golf Equipment & Supplies
Health Clubs
Instruction
Martial Arts
Recreation Facilities
Sporting Goods
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Auto Rentals
Hotels & Resorts
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Entertainment
Florists
Health & Beauty
Photographers & Videographers
Transportation
Apartments
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Corte Madera
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.37
-0.32 (-0.55%)
Official Closing Price
Updated: 7:00 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
66
67
Next >
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
October 17, 2024
HC Wainwright has initiated coverage on Alumis, highlighting the biopharmaceutical company's lead drug candidate, ESK-001. The analyst notes ESK-001's superior clinical data compared to Bristol Myers...
Via
Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
October 16, 2024
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
Via
The Motley Fool
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
October 15, 2024
The company could have a long path ahead to reimbursement and, ultimately, sales.
Via
Investor's Business Daily
Exposures
Product Safety
Johnson & Johnson Dividend Stock Analysis - Saturday, Oct. 12
October 12, 2024
Johnson & Johnson is a leader in the pharmaceutical, medical device, and consumer products industries. Here are some highlights from a quantitative analysis of the company's stock.
Via
Talk Markets
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
October 11, 2024
Perspective Therapeutics is down 13% at last check Friday. The downtrend comes as drug study results are presented to medical professionals.
Via
Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
October 07, 2024
Via
Benzinga
This Is What Whales Are Betting On Bristol-Myers Squibb
October 01, 2024
Via
Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
The FDA's approval of Bristol Myers Squibb's Cobenfy for schizophrenia opens doors for Reviva's brilaroxazine, a multi-receptor antipsychotic.
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Via
Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
October 07, 2024
Goldman Sachs raises S&P 500's EPS forecast to $268 in 2025, driven by AI tech demand & semiconductor recovery. Margin expansion & macro growth fuel optimism for tech & healthcare sectors.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
October 07, 2024
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion stake may spark a turnaround.
Via
Benzinga
Exposures
COVID-19
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
October 04, 2024
FDA approves Bristol Myers' Opdivo for resectable non-small cell lung cancer, reducing recurrence risk by 42% and showing 70% 18-month event-free survival in patients.
Via
Benzinga
Exposures
Product Safety
U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
October 03, 2024
From
Bristol Myers Squibb
Via
Business Wire
2 Passive-Income Stocks to Load Up On in October
October 03, 2024
These two dividend powerhouses are ideal choices for passive-income investors.
Via
The Motley Fool
Bristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
October 03, 2024
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
Via
Investor's Business Daily
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
October 01, 2024
IGM Biosciences shifts focus to autoimmune diseases, reduces oncology research, and appoints former Bristol Myers Squibb executive as CEO. The company aims to extend its cash runway into 2027.
Via
Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Changes are afoot at the company, and investors welcomed them.
Via
The Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Prime Medicine enters a strategic collaboration with Bristol Myers Squibb to develop next-gen T-cell therapies, securing $110 million upfront with potential for $3.5 billion in milestones. The company...
Via
Benzinga
Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies
September 30, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
These stocks might look like bad picks. But appearances can be deceiving.
Via
The Motley Fool
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
September 27, 2024
From
Bristol Myers Squibb
Via
Business Wire
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Bristol Myers' Cobenfy, recently approved by the FDA for schizophrenia, lacks a boxed warning, positioning it as a safer option. Analysts project peak sales of up to $5 billion if approved for...
Via
Benzinga
Exposures
Product Safety
Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting
September 27, 2024
From
Bristol Myers Squibb
Via
Business Wire
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
September 27, 2024
The Fed's preferred inflation gauge, the PCE Price Index, rose 2.2% YoY, below expectations. Decline in overall inflation suggests an easing of price pressures.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
September 27, 2024
Bristol Myers Squibb's Cobenfy has been approved by the FDA as the first new treatment for schizophrenia in decades. The medication introduces a new approach by targeting M1 and M4 receptors without...
Via
Benzinga
Exposures
Product Safety
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
September 27, 2024
Via
Benzinga
Wall Street On Wait-And-Watch Mode Ahead Of Inflation Data, Bitcoin Holds Above 65.5K: Analyst Says Volatility Ahead Providing Better Entry Point Into Long-term Bull Market
September 27, 2024
Sentiment has soured ahead of the key inflation data that is due ahead of the market open on Friday, with the index futures pointing to a modestly lower opening.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Signals Breakout
September 26, 2024
Cobenfy is the first drug to treat the disorder without blocking dopamine.
Via
Investor's Business Daily
Exposures
Product Safety
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
The FDA's advisory committee is set to evaluate the use of PD-1 inhibitors in gastric cancer patients, focusing on the risks and benefits for those with varying PD-L1 levels, including low expressers.
Via
Benzinga
Exposures
Product Safety
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
September 25, 2024
2seventy bio halts enrollment in its KarMMa-9 trial for Abecma, saving $80 million and focusing on profitability by 2025. Despite the decision, the company expects strong growth following FDA approval...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
66
67
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.